MUMBAI, India and NAPLES, Fla, May 5, 2026 /PRNewswire/ -- Global pharmaceutical leader Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) today announced that it has received approval from the United States Food and Drug … For the full story, visit the source.
BusinessMaharashtra
Lupin Receives U.S. FDA Approval for Glycerol Phenylbutyrate Oral Liquid
MUMBAI, India and NAPLES, Fla, May 5, 2026 /PRNewswire/ -- Global pharmaceutical leader Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) today announced that it has received approval from the United States Food and Drug …
PRNewswire· 5 months ago· 2 min read
This summary is sourced from PRNewswire. Read the full article at:PRNewswire